List of Tables
Table 1. Global Kidney Cancer Diagnostics Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Kidney Cancer Diagnostics Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Kidney Cancer Diagnostics Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Kidney Cancer Diagnostics Sales (K Units) by Region (2016-2021)
Table 5. Global Kidney Cancer Diagnostics Sales Market Share by Region (2016-2021)
Table 6. Global Kidney Cancer Diagnostics Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Kidney Cancer Diagnostics Revenue Share by Region (2016-2021)
Table 8. Global Kidney Cancer Diagnostics Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Kidney Cancer Diagnostics Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Kidney Cancer Diagnostics Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Kidney Cancer Diagnostics Revenue Share Forecast by Region (2022-2027)
Table 12. Global Kidney Cancer Diagnostics Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Kidney Cancer Diagnostics Sales Share by Company (2016-2021)
Table 14. Global Kidney Cancer Diagnostics Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Kidney Cancer Diagnostics Revenue Share by Company (2016-2021)
Table 16. Global Kidney Cancer Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney Cancer Diagnostics as of 2020)
Table 17. Global Kidney Cancer Diagnostics Average Price (US$/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Kidney Cancer Diagnostics Manufacturing Sites and Area Served
Table 19. Manufacturers Kidney Cancer Diagnostics Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Kidney Cancer Diagnostics Sales (K Units) by Type (2016-2021)
Table 22. Global Kidney Cancer Diagnostics Sales Share by Type (2016-2021)
Table 23. Global Kidney Cancer Diagnostics Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Kidney Cancer Diagnostics Price (US$/Unit) by Type (2016-2021)
Table 25. Global Kidney Cancer Diagnostics Sales Share by Type (2022-2027)
Table 26. Global Kidney Cancer Diagnostics Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Kidney Cancer Diagnostics Revenue Share by Type (2022-2027)
Table 28. Global Kidney Cancer Diagnostics Price (US$/Unit) by Type (2022-2027)
Table 29. Global Kidney Cancer Diagnostics Sales (K Units) by Application (2016-2021)
Table 30. Global Kidney Cancer Diagnostics Sales Share by Application (2016-2021)
Table 31. Global Kidney Cancer Diagnostics Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Kidney Cancer Diagnostics Price (US$/Unit) by Application (2016-2021)
Table 33. Global Kidney Cancer Diagnostics Sales (K Units) by Application (2022-2027)
Table 34. Global Kidney Cancer Diagnostics Sales Share by Application (2022-2027)
Table 35. Global Kidney Cancer Diagnostics Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Kidney Cancer Diagnostics Revenue Share by Application (2022-2027)
Table 37. Global Kidney Cancer Diagnostics Price (US$/Unit) by Application (2022-2027)
Table 38. North America Kidney Cancer Diagnostics Sales (K Units) by Company (2016-2021)
Table 39. North America Kidney Cancer Diagnostics Sales Market Share by Company (2016-2021)
Table 40. North America Kidney Cancer Diagnostics Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Kidney Cancer Diagnostics Revenue Market Share by Company (2016-2021)
Table 42. North America Kidney Cancer Diagnostics Sales by Type (2016-2021) & (K Units)
Table 43. North America Kidney Cancer Diagnostics Sales Market Share by Type (2016-2021)
Table 44. North America Kidney Cancer Diagnostics Sales by Type (2022-2027) & (K Units)
Table 45. North America Kidney Cancer Diagnostics Sales Market Share by Type (2022-2027)
Table 46. North America Kidney Cancer Diagnostics Sales by Application (2016-2021) & (K Units)
Table 47. North America Kidney Cancer Diagnostics Sales Market Share by Application (2016-2021)
Table 48. North America Kidney Cancer Diagnostics Sales by Application (2022-2027) & (K Units)
Table 49. North America Kidney Cancer Diagnostics Sales Market Share by Application (2022-2027)
Table 50. Europe Kidney Cancer Diagnostics Sales (K Units) by Company (2016-2021)
Table 51. Europe Kidney Cancer Diagnostics Sales Market Share by Company (2016-2021)
Table 52. Europe Kidney Cancer Diagnostics Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Kidney Cancer Diagnostics Revenue Market Share by Company (2016-2021)
Table 54. Europe Kidney Cancer Diagnostics Sales by Type (2016-2021) & (K Units)
Table 55. Europe Kidney Cancer Diagnostics Sales Market Share by Type (2016-2021)
Table 56. Europe Kidney Cancer Diagnostics Sales by Type (2022-2027) & (K Units)
Table 57. Europe Kidney Cancer Diagnostics Sales Market Share by Type (2022-2027)
Table 58. Europe Kidney Cancer Diagnostics Sales by Application (2016-2021) & (K Units)
Table 59. Europe Kidney Cancer Diagnostics Sales Market Share by Application (2016-2021)
Table 60. Europe Kidney Cancer Diagnostics Sales by Application (2022-2027) & (K Units)
Table 61. Europe Kidney Cancer Diagnostics Sales Market Share by Application (2022-2027)
Table 62. China Kidney Cancer Diagnostics Sales (K Units) by Company (2016-2021)
Table 63. China Kidney Cancer Diagnostics Sales Market Share by Company (2016-2021)
Table 64. China Kidney Cancer Diagnostics Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Kidney Cancer Diagnostics Revenue Market Share by Company (2016-2021)
Table 66. China Kidney Cancer Diagnostics Sales by Type (2016-2021) & (K Units)
Table 67. China Kidney Cancer Diagnostics Sales Market Share by Type (2016-2021)
Table 68. China Kidney Cancer Diagnostics Sales by Type (2022-2027) & (K Units)
Table 69. China Kidney Cancer Diagnostics Sales Market Share by Type (2022-2027)
Table 70. China Kidney Cancer Diagnostics Sales by Application (2016-2021) & (K Units)
Table 71. China Kidney Cancer Diagnostics Sales Market Share by Application (2016-2021)
Table 72. China Kidney Cancer Diagnostics Sales by Application (2022-2027) & (K Units)
Table 73. China Kidney Cancer Diagnostics Sales Market Share by Application (2022-2027)
Table 74. Japan Kidney Cancer Diagnostics Sales (K Units) by Company (2016-2021)
Table 75. Japan Kidney Cancer Diagnostics Sales Market Share by Company (2016-2021)
Table 76. Japan Kidney Cancer Diagnostics Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Kidney Cancer Diagnostics Revenue Market Share by Company (2016-2021)
Table 78. Japan Kidney Cancer Diagnostics Sales by Type (2016-2021) & (K Units)
Table 79. Japan Kidney Cancer Diagnostics Sales Market Share by Type (2016-2021)
Table 80. Japan Kidney Cancer Diagnostics Sales by Type (2022-2027) & (K Units)
Table 81. Japan Kidney Cancer Diagnostics Sales Market Share by Type (2022-2027)
Table 82. Japan Kidney Cancer Diagnostics Sales by Application (2016-2021) & (K Units)
Table 83. Japan Kidney Cancer Diagnostics Sales Market Share by Application (2016-2021)
Table 84. Japan Kidney Cancer Diagnostics Sales by Application (2022-2027) & (K Units)
Table 85. Japan Kidney Cancer Diagnostics Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Kidney Cancer Diagnostics Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Kidney Cancer Diagnostics Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Kidney Cancer Diagnostics Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Kidney Cancer Diagnostics Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Kidney Cancer Diagnostics Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Kidney Cancer Diagnostics Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Kidney Cancer Diagnostics Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Kidney Cancer Diagnostics Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Kidney Cancer Diagnostics Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Kidney Cancer Diagnostics Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Kidney Cancer Diagnostics Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Kidney Cancer Diagnostics Sales Market Share by Application (2022-2027)
Table 98. India Kidney Cancer Diagnostics Sales (K Units) by Company (2016-2021)
Table 99. India Kidney Cancer Diagnostics Sales Market Share by Company (2016-2021)
Table 100. India Kidney Cancer Diagnostics Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Kidney Cancer Diagnostics Revenue Market Share by Company (2016-2021)
Table 102. India Kidney Cancer Diagnostics Sales by Type (2016-2021) & (K Units)
Table 103. India Kidney Cancer Diagnostics Sales Market Share by Type (2016-2021)
Table 104. India Kidney Cancer Diagnostics Sales by Type (2022-2027) & (K Units)
Table 105. India Kidney Cancer Diagnostics Sales Market Share by Type (2022-2027)
Table 106. India Kidney Cancer Diagnostics Sales by Application (2016-2021) & (K Units)
Table 107. India Kidney Cancer Diagnostics Sales Market Share by Application (2016-2021)
Table 108. India Kidney Cancer Diagnostics Sales by Application (2022-2027) & (K Units)
Table 109. India Kidney Cancer Diagnostics Sales Market Share by Application (2022-2027)
Table 110. Thermo Fisher Scientific Corporation Information
Table 111. Thermo Fisher Scientific Description and Business Overview
Table 112. Thermo Fisher Scientific Kidney Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Thermo Fisher Scientific Kidney Cancer Diagnostics Product
Table 114. Thermo Fisher Scientific Recent Development
Table 115. Abbott Laboratories Corporation Information
Table 116. Abbott Laboratories Description and Business Overview
Table 117. Abbott Laboratories Kidney Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Abbott Laboratories Kidney Cancer Diagnostics Product
Table 119. Abbott Laboratories Recent Development
Table 120. Illumina Corporation Information
Table 121. Illumina Description and Business Overview
Table 122. Illumina Kidney Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Illumina Kidney Cancer Diagnostics Product
Table 124. Illumina Recent Development
Table 125. Quest Diagnostics Incorporated Corporation Information
Table 126. Quest Diagnostics Incorporated Description and Business Overview
Table 127. Quest Diagnostics Incorporated Kidney Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Quest Diagnostics Incorporated Kidney Cancer Diagnostics Product
Table 129. Quest Diagnostics Incorporated Recent Development
Table 130. Roche Holding Corporation Information
Table 131. Roche Holding Description and Business Overview
Table 132. Roche Holding Kidney Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Roche Holding Kidney Cancer Diagnostics Product
Table 134. Roche Holding Recent Development
Table 135. Myriad Genetics Corporation Information
Table 136. Myriad Genetics Description and Business Overview
Table 137. Myriad Genetics Kidney Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Myriad Genetics Kidney Cancer Diagnostics Product
Table 139. Myriad Genetics Recent Development
Table 140. NeoGenomics Laboratories Corporation Information
Table 141. NeoGenomics Laboratories Description and Business Overview
Table 142. NeoGenomics Laboratories Kidney Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. NeoGenomics Laboratories Kidney Cancer Diagnostics Product
Table 144. NeoGenomics Laboratories Recent Development
Table 145. NanoString Technologies Corporation Information
Table 146. NanoString Technologies Kidney Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. NanoString Technologies Description and Business Overview
Table 148. NanoString Technologies Kidney Cancer Diagnostics Product
Table 149. NanoString Technologies Recent Development
Table 150. Sysmex Corporation Corporation Information
Table 151. Sysmex Corporation Kidney Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 152. Sysmex Corporation Description and Business Overview
Table 153. Sysmex Corporation Kidney Cancer Diagnostics Product
Table 154. Sysmex Corporation Recent Development
Table 155. Rosetta Genomics Corporation Information
Table 156. Rosetta Genomics Description and Business Overview
Table 157. Rosetta Genomics Kidney Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 158. Rosetta Genomics Kidney Cancer Diagnostics Product
Table 159. Rosetta Genomics Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Kidney Cancer Diagnostics Distributors List
Table 163. Kidney Cancer Diagnostics Customers List
Table 164. Kidney Cancer Diagnostics Market Trends
Table 165. Kidney Cancer Diagnostics Market Drivers
Table 166. Kidney Cancer Diagnostics Market Challenges
Table 167. Kidney Cancer Diagnostics Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Kidney Cancer Diagnostics Product Picture
Figure 2. Global Kidney Cancer Diagnostics Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Kidney Cancer Diagnostics Sales Market Share by Application in 2021 & 2027
Figure 6. Hospitals Examples
Figure 7. Specialty Clinics Examples
Figure 8. Others Examples
Figure 9. Global Kidney Cancer Diagnostics Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Kidney Cancer Diagnostics Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Kidney Cancer Diagnostics Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Kidney Cancer Diagnostics Price Trends Growth Rate (2016-2027) (US$/Unit)
Figure 13. Global Kidney Cancer Diagnostics Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Kidney Cancer Diagnostics Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Kidney Cancer Diagnostics Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Kidney Cancer Diagnostics Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Kidney Cancer Diagnostics Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Kidney Cancer Diagnostics Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Kidney Cancer Diagnostics Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Kidney Cancer Diagnostics Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Kidney Cancer Diagnostics Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Kidney Cancer Diagnostics Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Kidney Cancer Diagnostics Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Kidney Cancer Diagnostics Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Kidney Cancer Diagnostics Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Kidney Cancer Diagnostics Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Kidney Cancer Diagnostics Players Market Share by Revenue in Kidney Cancer Diagnostics: 2016 & 2020
Figure 28. Kidney Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Kidney Cancer Diagnostics Revenue Share by Type (2016-2021)
Figure 30. Global Kidney Cancer Diagnostics Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Kidney Cancer Diagnostics Revenue Share by Application (2016-2021)
Figure 32. Global Kidney Cancer Diagnostics Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Kidney Cancer Diagnostics Sales Market Share by Type in 2020
Figure 34. North America Kidney Cancer Diagnostics Sales Market Share by Application in 2020
Figure 35. Europe Kidney Cancer Diagnostics Sales Market Share by Type in 2020
Figure 36. Europe Kidney Cancer Diagnostics Sales Market Share by Application in 2020
Figure 37. China Kidney Cancer Diagnostics Sales Market Share by Type in 2020
Figure 38. China Kidney Cancer Diagnostics Sales Market Share by Application in 2020
Figure 39. Japan Kidney Cancer Diagnostics Sales Market Share by Type in 2020
Figure 40. Japan Kidney Cancer Diagnostics Sales Market Share by Application in 2020
Figure 41. Southeast Asia Kidney Cancer Diagnostics Sales Market Share by Type in 2020
Figure 42. Southeast Asia Kidney Cancer Diagnostics Sales Market Share by Application in 2020
Figure 43. India Kidney Cancer Diagnostics Sales Market Share by Type in 2020
Figure 44. India Kidney Cancer Diagnostics Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Kidney Cancer Diagnostics
Figure 47. Manufacturing Process Analysis of Kidney Cancer Diagnostics
Figure 48. Kidney Cancer Diagnostics Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
